Baidu
map

100个项目将晋级首届全国中医药高校大学生创新创业大赛总决赛

2017-11-08 秦宇龙 中国中医

11月6日,首届全国中医药高等院校大学生创新创业大赛新闻发布会在京召开。本次大赛以“创新·融合·发展”为主题,旨在弘扬传统中医药文化精神,激发中医药健康事业活力,培养中医药大学生的创新精神、创业意识和创新创业能力。广州中医药大学、南京中医药大学、长春中医药大学等22所中医药高等院校参与。

11月6日,首届全国中医药高等院校大学生创新创业大赛新闻发布会在京召开。本次大赛以“创新·融合·发展”为主题,旨在弘扬传统中医药文化精神,激发中医药健康事业活力,培养中医药大学生的创新精神、创业意识和创新创业能力。广州中医药大学、南京中医药大学、长春中医药大学等22所中医药高等院校参与。

北京中医药大学校长徐安龙在讲话中指出,要在传承中医药核心思想的基础上开展创新。青年学生是创新的主体,是开展创新创业的主力军和中坚力量,让学生在中医药领域更高质量地创新创业,才能将中医药的宝贵财富传承下去。他表示,希望本次大赛可以激励中医药学子为中医药的传承创新铺设一条独特之路。

北京中医药大学大学生创新创业教育中心副主任田润平从组织形式、赛程安排、奖项设置等方面对本次大赛做了介绍,并正式发布大赛标志以及大赛吉祥物。随后,大赛组委会就媒体记者提出的问题进行解答。


大赛吉祥物


大赛赛标

首届全国中医药高等院校大学生创新创业大赛由全国中医药高等教育学会、中华中医药学会主办,北京中医药大学承办。

目前,大赛网络报名和校级初赛已经全部完成,接下来将开展网上评审、全国总决赛两个阶段的赛事。通过校级初赛,全国共产生487个项目入围网上评审;通过网上评审,将有100个项目晋级全国总决赛。大赛全国总决赛将于11月25~26日在北京中医药大学举行。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1910079, encodeId=161a19100e992, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Aug 12 14:16:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285457, encodeId=011f128545e44, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409166, encodeId=279d1409166f5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513812, encodeId=3742151381250, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555065, encodeId=c8f4155506559, content=<a href='/topic/show?id=3991102429e4' target=_blank style='color:#2F92EE;'>#高校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102429, encryptionId=3991102429e4, topicName=高校)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e14588816, createdName=zjubiostat, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259800, encodeId=719325980072, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Nov 08 21:31:45 CST 2017, time=2017-11-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1910079, encodeId=161a19100e992, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Aug 12 14:16:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285457, encodeId=011f128545e44, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409166, encodeId=279d1409166f5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513812, encodeId=3742151381250, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555065, encodeId=c8f4155506559, content=<a href='/topic/show?id=3991102429e4' target=_blank style='color:#2F92EE;'>#高校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102429, encryptionId=3991102429e4, topicName=高校)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e14588816, createdName=zjubiostat, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259800, encodeId=719325980072, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Nov 08 21:31:45 CST 2017, time=2017-11-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1910079, encodeId=161a19100e992, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Aug 12 14:16:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285457, encodeId=011f128545e44, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409166, encodeId=279d1409166f5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513812, encodeId=3742151381250, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555065, encodeId=c8f4155506559, content=<a href='/topic/show?id=3991102429e4' target=_blank style='color:#2F92EE;'>#高校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102429, encryptionId=3991102429e4, topicName=高校)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e14588816, createdName=zjubiostat, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259800, encodeId=719325980072, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Nov 08 21:31:45 CST 2017, time=2017-11-08, status=1, ipAttribution=)]
    2017-11-10 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1910079, encodeId=161a19100e992, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Aug 12 14:16:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285457, encodeId=011f128545e44, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409166, encodeId=279d1409166f5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513812, encodeId=3742151381250, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555065, encodeId=c8f4155506559, content=<a href='/topic/show?id=3991102429e4' target=_blank style='color:#2F92EE;'>#高校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102429, encryptionId=3991102429e4, topicName=高校)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e14588816, createdName=zjubiostat, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259800, encodeId=719325980072, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Nov 08 21:31:45 CST 2017, time=2017-11-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1910079, encodeId=161a19100e992, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Aug 12 14:16:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285457, encodeId=011f128545e44, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409166, encodeId=279d1409166f5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513812, encodeId=3742151381250, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555065, encodeId=c8f4155506559, content=<a href='/topic/show?id=3991102429e4' target=_blank style='color:#2F92EE;'>#高校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102429, encryptionId=3991102429e4, topicName=高校)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e14588816, createdName=zjubiostat, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259800, encodeId=719325980072, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Nov 08 21:31:45 CST 2017, time=2017-11-08, status=1, ipAttribution=)]
    2017-11-10 zjubiostat
  6. [GetPortalCommentsPageByObjectIdResponse(id=1910079, encodeId=161a19100e992, content=<a href='/topic/show?id=21574368886' target=_blank style='color:#2F92EE;'>#大学生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43688, encryptionId=21574368886, topicName=大学生)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Sun Aug 12 14:16:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285457, encodeId=011f128545e44, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409166, encodeId=279d1409166f5, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513812, encodeId=3742151381250, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1555065, encodeId=c8f4155506559, content=<a href='/topic/show?id=3991102429e4' target=_blank style='color:#2F92EE;'>#高校#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102429, encryptionId=3991102429e4, topicName=高校)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=674e14588816, createdName=zjubiostat, createdTime=Fri Nov 10 12:16:00 CST 2017, time=2017-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=259800, encodeId=719325980072, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Wed Nov 08 21:31:45 CST 2017, time=2017-11-08, status=1, ipAttribution=)]
    2017-11-08 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0

相关资讯

速收藏!全国理想医院大全

速收藏!全国最好医院大全

阜外医院报告全国很大宗完全性肺静脉异位引流手术经验:1岁内患儿死亡风险高

近期,阜外医院侯剑峰等对该院563例完全性肺静脉异位引流患者围手术期死亡危险因素进行了分析。

宁光院士:年底前全国20个省市将建100个代谢中心

宁光表示,目前全国已陆续建设了20几家代谢中心,到今年年底,将在全国20个省市铺开100个代谢中心,预计到2018年能够达到500家,到2020年能够建成1000家。中心都将采用标准、统一的方式去治疗糖尿病和其他代谢性疾病,真正能够实现代谢性疾病的一体化、标准化管理和一站式服务。

9月起,这些政策将影响全国医生!

9月,真的是2017医疗大变革的时间点,最近小编发现很多年初的重磅政策都在本月实施了,如果你没有察觉到,也只能是只缘身在此山中了。

这七大医改动作,影响全国医生!

11月7日,全国卫生计生人才工作会在河南郑州召开。据会议获悉,医疗圈流传已久的诸多福利政策都被坐实了,这7大亮点值得全国医务人员关注:

提升疑难病诊治能力 国家卫计委遴选一百家医院获资金支持

为提升疑难病症诊治能力,9月19日,国家卫计委联合国家发改委发布《疑难病症诊治能力提升工程项目遴选工作方案》。

Baidu
map
Baidu
map
Baidu
map